What Is End-of-Life Care for Relapsed or Refractory DLBCL?
By CRYSTAL BAI •
The short answer: Relapsed or refractory DLBCL after CAR-T or second-line therapy has very limited curative options. End-of-life care focuses on managing cytopenias, infections, constitutional symptoms, and organ involvement through palliative and hospice support with early goals-of-care planning.
Understanding Relapsed/Refractory DLBCL at End of Life
Diffuse large B-cell lymphoma (DLBCL) that has relapsed after or is refractory to CAR-T cell therapy represents a critical juncture. Further salvage options are limited, and the prognosis is poor. When clinical trial options are not available or desired, end-of-life care becomes the appropriate focus.
Symptom Burden in Advanced DLBCL
Relapsed DLBCL causes rapidly enlarging lymph nodes (potentially causing obstruction), systemic B-symptoms (fever, night sweats, weight loss), severe cytopenias requiring transfusion support, and organ involvement depending on disease sites. CNS involvement causes neurological symptoms. GI involvement causes obstruction and bleeding.
Palliative Care and Symptom Management
Palliative interventions include transfusions for symptomatic anemia, infection prevention and management, radiation for specific symptomatic sites, corticosteroids for B-symptoms and inflammation, and opioid analgesics for pain. Goals-of-care conversations should clarify patient preferences about invasive interventions (intubation, CPR) clearly and early.
Transition to Hospice
Hospice for relapsed DLBCL should be considered when clinical trial eligibility is absent or declined, further salvage is not viable, and the patient's prognosis is six months or less. The transition should be proactive to ensure comprehensive symptom management from the outset.
Frequently Asked Questions
What is relapsed or refractory DLBCL?
DLBCL that returns or doesn't respond after CAR-T or second-line therapy is called relapsed/refractory, with very limited additional curative options.
When should a relapsed DLBCL patient consider hospice?
Hospice is appropriate when further active therapy is not available or desired, prognosis is six months or less, and the focus shifts to comfort and quality of life.
What symptoms are managed at end of life with DLBCL?
Key symptoms include lymph node enlargement, B-symptoms, cytopenias, organ obstruction, infections, and pain from disease burden.
Can a death doula help a family facing relapsed DLBCL end of life?
Yes. A death doula provides family support, legacy work, and companionship — particularly valuable during the often rapid end-stage trajectory of refractory lymphoma.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.